Simon, Christopher 4
4 · HAEMONETICS CORP · Filed Jun 30, 2023
Insider Transaction Report
Form 4
Simon, Christopher
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2023-06-29$28.61/sh+196,746$5,629,887→ 414,113 total - Tax Payment
Common Stock
2023-06-29$84.84/sh−117,667$9,982,868→ 296,446 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2023-06-29−196,746→ 0 totalExercise: $28.61From: 2017-06-29Exp: 2023-06-29→ Common Stock (196,746 underlying)
Footnotes (4)
- [F1]Represents an automatic exercise of options granted in 2016 and scheduled to expire after June 29, 2023, as reflected in this Form 4.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.